Automated volumetric assessment of hepatocellular carcinoma response to sorafenib: A pilot study

David Fuentes, Kareem Ahmed, Jonathan S. Lin, Reham Abdel-Wahab, Ahmed O. Kaseb, Manal Hassan, Janio Szklaruk, Ali Morshid, John D. Hazle, Aliya Qayyum, Khaled M. Elsayes

Research output: Contribution to journalArticle

1 Scopus citations


Purpose: This pilot study evaluates the feasibility of automated volumetric quantification of hepatocellular carcinoma (HCC) as an imaging biomarker to assess treatment response for sorafenib. Methods: In this institutional review board-approved, Health Insurance Portability and Accountability Act-compliant retrospective study, a training database of manually labeled background liver, enhancing and nonenhancing tumor tissue was established using pretherapy and first posttherapy multiphasic computed tomography images from a registry of 13 HCC patients. For each patient, Hounsfield density and geometry-based feature images were generated from registered multiphasic computed tomography data sets and used as the input for a random forest-based classifier of enhancing and nonenhancing tumor tissue. Leave-one-out cross-validation of the dice similarity measure was applied to quantify the classifier accuracy. A Cox regression model was used to confirm volume changes as predictors of time to progression (TTP) of target lesions for both manual and automatic methods. Results: When compared with manual labels, an overall classification accuracy of dice similarity coefficient of 0.71 for pretherapy and 0.66 posttherapy enhancing tumor labels and 0.45 for pretherapy and 0.59 for posttherapy nonenhancing tumor labels was observed. Automated methods for quantifying volumetric changes in the enhancing lesion agreed with manual methods and were observed as a significant predictor of TTP. Conclusions: Automated volumetric analysis was determined to be feasible for monitoring HCC response to treatment. The information extracted using automated volumetrics is likely to reproduce labor-intensive manual data and provide a good predictor for TTP. Further work will extend these studies to additional treatment modalities and larger patient populations.

Original languageEnglish (US)
Pages (from-to)499-506
Number of pages8
JournalJournal of computer assisted tomography
Issue number3
StatePublished - Jan 1 2019


  • HCC
  • Image segmentation
  • Random forest
  • Sorafenib
  • Treatment response

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Automated volumetric assessment of hepatocellular carcinoma response to sorafenib: A pilot study'. Together they form a unique fingerprint.

  • Cite this